The Eugene Bell Foundation treats North Korean patients with multidrug-resistant tuberculosis (MDR-TB), a deadly but curable disease. As the only large organization treating MDR-TB in North Korea, we are the last, best hope for hundreds of patients all across the country. Learn more about what makes MDR-TB so dangerous and how you can stop it at www.eugene-bell.org

Tuberculosis is one of the most dangerous diseases. 19% of the population are facing death because of TB. Every minute one person dies because of T.B.Awareness is the best cure. Tuber in very commonly called as blockage. It is a serious infectious bacterial disease, which effects lungs. Through our presentation, know how TB is effecting people, what are the causes and effects of tuberculosis.
Careworldtv Channel is the #1 destination for Fitness & Lifestyle content on YouTube. Careworldtv helps you become a better you with how-to videos covering everything from exercise, diet, and healthy living to style, makeup, and fashion tips.
Stay tuned to watch more How to, Beauty, Health & Lifestyle videos.
Subscribe - http://www.youtube.com/subscription_center?add_user=careworldtv
Watch more amazing videos from careworldtv;
Beauty Tips - https://www.youtube.com/playlist?list=PLUG4hbjc2bbIY4IOdnjuUBOtWqMivehu1
Lifestyle Tips - https://www.youtube.com/playlist?list=PLUG4hbjc2bbIIyJko3mZcMrInwXDb7Xr6
Infertility Issues - https://www.youtube.com/playlist?list=PLUG4hbjc2bbLPPbL2WxGLsK0F6crsDmTN
Health Plus - https://www.youtube.com/playlist?list=PLUG4hbjc2bbKQG9OYRq0-4WtIJMCpjqwA
Kya Karu Mai ABB - https://www.youtube.com/playlist?list=PLUG4hbjc2bbKffKelWm5Z7_y81D-SJLYu
Fashion Tips by Gorgeous You - https://www.youtube.com/playlist?list=PLUG4hbjc2bbLQN60z7hUxhfmFyHk4Wxhx
Healthy Recipes - https://www.youtube.com/playlist?list=PLUG4hbjc2bbK_KUiNi1MCFka1xni6A1bz
Fitness Expert - https://www.youtube.com/playlist?list=PLUG4hbjc2bbK3-tsJfgX4cUnJ6nKAirqB
Wedding and bridal beauty tips - https://www.youtube.com/playlist?list=PLUG4hbjc2bbINDauWM-fUaXtBBCYFYFii

Learn the different types of drug-resistant TB These videos do not provide medical advice and are for informational purposes only. The videos are not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen in any Khan Academy video. Created by Stanford School of Medicine.
Watch the next lesson: https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/tuberculosis-rn/v/tb-and-hiv?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn
Missed the previous lesson? https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/tuberculosis-rn/v/treatment-of-active-tb?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn
NCLEX-RN on Khan Academy: A collection of questions from content covered on the NCLEX-RN. These questions are available under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0United StatesLicense (available at http://creativecommons.org/licenses/by-nc-sa/3.0/us/).
About Khan Academy: Khan Academy offers practice exercises, instructional videos, and a personalized learning dashboard that empower learners to study at their own pace in and outside of the classroom. We tackle math, science, computer programming, history, art history, economics, and more. Our math missions guide learners from kindergarten to calculus using state-of-the-art, adaptive technology that identifies strengths and learning gaps. We've also partnered with institutions like NASA, The Museum of Modern Art, The California Academy of Sciences, and MIT to offer specialized content.
For free. For everyone. Forever. #YouCanLearnAnything
Subscribe to Khan Academy’s NCLEX-RN channel: https://www.youtube.com/channel/UCDx5cTeADCvKWgF9x_Qjz3g?sub_confirmation=1
Subscribe to Khan Academy: https://www.youtube.com/subscription_center?add_user=khanacademy

published:10 Jun 2013

views:42109

HelloEveryone!
This video features about Drug Resistant TB and What Should You Know about TB or Tuberculosis disease.
Thanks for watching! please let me know what you wanna see next.
Help Us Like & Share This Video. Don't forget to Subscribe & comment below. Thanks!
★★★★★★★★★★★★★★★★★★★
PLEASE SUBSCRIBE FOR MORE!!!
★★★★★★★★★★★★★★★★★★★
Written Updates!
Tuberculosis is one of the top 10 causes of death worldwide and India has the maximum number of cases of this deadly but curable and treatable disease. The World Health Organization’s Global Tuberculosis Report in 2016 estimates that there are 79,000 cases of MDR-TB or Multi-Drug Resistance Tuberculosis. This is becoming a serious problem and a big public health issue.
Tuberculosis is a disease caused by the bacteria Mycobacterium Tuberculosis. It is spread from person to person through the air. When people affected with tuberculosis sneeze, spit or cough, the bacteria goes into the air and if someone inhales these germs, they can become affected. It usually affects the lungs but can also spread to all other organs of the body.
Symptoms of tuberculosis include cough, low grade fever, night sweats or unexplained weight loss. When a person develops tuberculosis, they can have mild symptoms for many months before being detected with the infection. People affected with HIV are 20 to 30 more times likely to develop active tuberculosis.
Drug-Resistant Tuberculosis
An active case of tuberculosis usually can be treated with a standard 6 month course of 4 anti-Tb drugs. Since these medications have been used for many years, new forms of Tb that are resistant to the standard Tb drugs are being seen.
There are multiple forms of Drug Resistant Tuberculosis that includes
1. Multi Drug Resistant Tb or MDR-TB.
2. Extensively-Drug Resistant Tb or XDR-TB.
3. Extremely drug resistant TB or XXDR.
Various reasons have lead to drug resistant form of tuberculosis
1. Delays in Detection and Referral.
2. Adherence to Treatment Regimens.
3. Expensive Drug Regimens.
According to the WHO, 480,000 people were affected with MDR-TB in 2015 worldwide. In India, it is estimated that 2.5% of all new TB cases are MDR-TB.

published:28 Mar 2017

views:1411

The first new TB drug in 40 years brings hope to patients. Arman is one of 450,000 people per year worldwide who are infected with a dangerous, mutated version of one of the world's deadliest diseases - tuberculosis (TB). The illness kills 1.3 million people per year, more than any other infectious disease apart from HIV/AIDS.

published:27 May 2014

views:3887

published:19 May 2017

views:4091

This is the story of Maricel, a survivor and advocate of multidrug-resistant tuberculosis (MDR-TB).
Learn more about MDR-TB: http://www.who.int/features/qa/79/en/

published:18 Nov 2017

views:616

A young, dangerously emaciated girl in Lesotho is examined and treated at a specialized TB facility, in an attempt to reverse her life threatening condition(s).

Multi-drug-resistant tuberculosis

Multi-drug-resistant tuberculosis (MDR-TB, also known as Vank's Disease) is defined as a form of TB infection caused by bacteria that are resistant to treatment with at least two of the most powerful first-lineanti-TB drugs,isoniazid (INH) and rifampicin (RMP).

Five percent (5%) of all TB cases across the globe in 2013 were estimated to be MDR-TB cases, including 3.5% of newly diagnosed TB cases, and 20.5% of previously treated TB cases. While rates of MDR-TB infections are relatively low in North America and Western Europe, they are an increasingly serious problem worldwide, in particular in areas of the Russian Federation, the former Soviet Union and other parts of Asia.

MDR-TB infection may be classified as either primary or acquired. Primary MDR-TB occurs in patients who have not previously been infected with TB but who become infected with a strain that is resistant to treatment. Acquired MDR-TB occurs in patients during treatment with a drug regimen that is not effective at killing the particular strain of TB with which they have been infected. Rates of primary MDR-TB are low in North America and Western Europe: in the US in 2000, the rate of primary MDR-TB was 1% of all cases of TB nationally. Most cases of acquired MDR-TB are due to inappropriate treatment with a single anti-TB drug, usually INH. This can occur due to a medical provider, such as a doctor or nurse, improperly prescribing ineffective treatment, but may also be due to the patient not taking the medication correctly, which can be due to a variety of reasons, including expense or scarcity of medicines, patient forgetfulness, or patient stopping treatment early because they feel better.

Khan Academy

Khan Academy is a non-profit educational organization created in 2006 by educator Salman Khan with the aim of providing a free, world-class education for anyone, anywhere. The organization produces short lectures in the form of YouTube videos. In addition to micro lectures, the organization's website features practice exercises and tools for educators. All resources are available for free to anyone around the world. The main language of the website is English, but the content is also available in other languages.

In late 2004, Khan began tutoring his cousin Nadia who needed help with math using Yahoo!'s Doodle notepad.When other relatives and friends sought similar help, he decided that it would be more practical to distribute the tutorials on YouTube. The videos' popularity and the testimonials of appreciative students prompted Khan to quit his job in finance as a hedge fund analyst at Connective Capital Management in 2009, and focus on the tutorials (then released under the moniker "Khan Academy") full-time.

What is MDR-TB?

The Eugene Bell Foundation treats North Korean patients with multidrug-resistant tuberculosis (MDR-TB), a deadly but curable disease. As the only large organization treating MDR-TB in North Korea, we are the last, best hope for hundreds of patients all across the country. Learn more about what makes MDR-TB so dangerous and how you can stop it at www.eugene-bell.org

MDR Tuberculosis and Cure - Multi Drug Resistant T.B - Health Plus

Tuberculosis is one of the most dangerous diseases. 19% of the population are facing death because of TB. Every minute one person dies because of T.B.Awareness is the best cure. Tuber in very commonly called as blockage. It is a serious infectious bacterial disease, which effects lungs. Through our presentation, know how TB is effecting people, what are the causes and effects of tuberculosis.
Careworldtv Channel is the #1 destination for Fitness & Lifestyle content on YouTube. Careworldtv helps you become a better you with how-to videos covering everything from exercise, diet, and healthy living to style, makeup, and fashion tips.
Stay tuned to watch more How to, Beauty, Health & Lifestyle videos.
Subscribe - http://www.youtube.com/subscription_center?add_user=careworldtv
Watch more amazing videos from careworldtv;
Beauty Tips - https://www.youtube.com/playlist?list=PLUG4hbjc2bbIY4IOdnjuUBOtWqMivehu1
Lifestyle Tips - https://www.youtube.com/playlist?list=PLUG4hbjc2bbIIyJko3mZcMrInwXDb7Xr6
Infertility Issues - https://www.youtube.com/playlist?list=PLUG4hbjc2bbLPPbL2WxGLsK0F6crsDmTN
Health Plus - https://www.youtube.com/playlist?list=PLUG4hbjc2bbKQG9OYRq0-4WtIJMCpjqwA
Kya Karu Mai ABB - https://www.youtube.com/playlist?list=PLUG4hbjc2bbKffKelWm5Z7_y81D-SJLYu
Fashion Tips by Gorgeous You - https://www.youtube.com/playlist?list=PLUG4hbjc2bbLQN60z7hUxhfmFyHk4Wxhx
Healthy Recipes - https://www.youtube.com/playlist?list=PLUG4hbjc2bbK_KUiNi1MCFka1xni6A1bz
Fitness Expert - https://www.youtube.com/playlist?list=PLUG4hbjc2bbK3-tsJfgX4cUnJ6nKAirqB
Wedding and bridal beauty tips - https://www.youtube.com/playlist?list=PLUG4hbjc2bbINDauWM-fUaXtBBCYFYFii

MDR TB in India

Drug-resistant TB | Infectious diseases | NCLEX-RN | Khan Academy

Learn the different types of drug-resistant TB These videos do not provide medical advice and are for informational purposes only. The videos are not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen in any Khan Academy video. Created by Stanford School of Medicine.
Watch the next lesson: https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/tuberculosis-rn/v/tb-and-hiv?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn
Missed the previous lesson? https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/tuberculosis-rn/v/treatment-of-active-tb?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn
NCLEX-RN on Khan Academy: A collection of questions from content covered on the NCLEX-RN. These questions are available under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0United StatesLicense (available at http://creativecommons.org/licenses/by-nc-sa/3.0/us/).
About Khan Academy: Khan Academy offers practice exercises, instructional videos, and a personalized learning dashboard that empower learners to study at their own pace in and outside of the classroom. We tackle math, science, computer programming, history, art history, economics, and more. Our math missions guide learners from kindergarten to calculus using state-of-the-art, adaptive technology that identifies strengths and learning gaps. We've also partnered with institutions like NASA, The Museum of Modern Art, The California Academy of Sciences, and MIT to offer specialized content.
For free. For everyone. Forever. #YouCanLearnAnything
Subscribe to Khan Academy’s NCLEX-RN channel: https://www.youtube.com/channel/UCDx5cTeADCvKWgF9x_Qjz3g?sub_confirmation=1
Subscribe to Khan Academy: https://www.youtube.com/subscription_center?add_user=khanacademy

3:17

Drug Resistant TB - What Should You Know

Drug Resistant TB - What Should You Know

Drug Resistant TB - What Should You Know

HelloEveryone!
This video features about Drug Resistant TB and What Should You Know about TB or Tuberculosis disease.
Thanks for watching! please let me know what you wanna see next.
Help Us Like & Share This Video. Don't forget to Subscribe & comment below. Thanks!
★★★★★★★★★★★★★★★★★★★
PLEASE SUBSCRIBE FOR MORE!!!
★★★★★★★★★★★★★★★★★★★
Written Updates!
Tuberculosis is one of the top 10 causes of death worldwide and India has the maximum number of cases of this deadly but curable and treatable disease. The World Health Organization’s Global Tuberculosis Report in 2016 estimates that there are 79,000 cases of MDR-TB or Multi-Drug Resistance Tuberculosis. This is becoming a serious problem and a big public health issue.
Tuberculosis is a disease caused by the bacteria Mycobacterium Tuberculosis. It is spread from person to person through the air. When people affected with tuberculosis sneeze, spit or cough, the bacteria goes into the air and if someone inhales these germs, they can become affected. It usually affects the lungs but can also spread to all other organs of the body.
Symptoms of tuberculosis include cough, low grade fever, night sweats or unexplained weight loss. When a person develops tuberculosis, they can have mild symptoms for many months before being detected with the infection. People affected with HIV are 20 to 30 more times likely to develop active tuberculosis.
Drug-Resistant Tuberculosis
An active case of tuberculosis usually can be treated with a standard 6 month course of 4 anti-Tb drugs. Since these medications have been used for many years, new forms of Tb that are resistant to the standard Tb drugs are being seen.
There are multiple forms of Drug Resistant Tuberculosis that includes
1. Multi Drug Resistant Tb or MDR-TB.
2. Extensively-Drug Resistant Tb or XDR-TB.
3. Extremely drug resistant TB or XXDR.
Various reasons have lead to drug resistant form of tuberculosis
1. Delays in Detection and Referral.
2. Adherence to Treatment Regimens.
3. Expensive Drug Regimens.
According to the WHO, 480,000 people were affected with MDR-TB in 2015 worldwide. In India, it is estimated that 2.5% of all new TB cases are MDR-TB.

10:27

Tackling Drug-Resistant TB

Tackling Drug-Resistant TB

Tackling Drug-Resistant TB

The first new TB drug in 40 years brings hope to patients. Arman is one of 450,000 people per year worldwide who are infected with a dangerous, mutated version of one of the world's deadliest diseases - tuberculosis (TB). The illness kills 1.3 million people per year, more than any other infectious disease apart from HIV/AIDS.

5:40

MDR TB slide show

MDR TB slide show

MDR TB slide show

7:58

A Multidrug-Resistant TB Patient's Story

A Multidrug-Resistant TB Patient's Story

A Multidrug-Resistant TB Patient's Story

This is the story of Maricel, a survivor and advocate of multidrug-resistant tuberculosis (MDR-TB).
Learn more about MDR-TB: http://www.who.int/features/qa/79/en/

5:18

Treating Pulane - MDR-TB, PIH Lesotho

Treating Pulane - MDR-TB, PIH Lesotho

Treating Pulane - MDR-TB, PIH Lesotho

A young, dangerously emaciated girl in Lesotho is examined and treated at a specialized TB facility, in an attempt to reverse her life threatening condition(s).

7:00

recover story of lady from MDR TB on Satyamev Jayate on 26th October 2014

recover story of lady from MDR TB on Satyamev Jayate on 26th October 2014

recover story of lady from MDR TB on Satyamev Jayate on 26th October 2014

Surviving MDR-TB: My Story, My Voice

MDR-TB Patients Speak TDF 2009.wmv

2:50

MDR-TB: Speeding up research efforts

MDR-TB: Speeding up research efforts

MDR-TB: Speeding up research efforts

Ignored for the past fifty years, the needs of patients suffering from tuberculosis are finally being addressed... especially for patients with a multi-drug resistant form of the disease, who can now hope to have access to effective treatments within the next few years.
So why are these new treatments needed so badly? Multi-drug resistant tuberculosis is a real killer, and a major public health issue.
Tuberculosis, or TB, is an infectious disease that is treated with antibiotics. But some bacteria have found ways to resist or fght off the drug due to incorrectly administered treatment. When the two main antibiotics stop being effective against the disease, it is labelled multi-drug resistant tuberculosis, or MDR-TB
These are the 27 worst affected countries: Armenia, Azerbaijan, Bangladesh, Belorussia, Bulgaria, Chine, DRC, Ethiopia, Estonia, India, Indonesia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Moldavia, Myanmar, Nigeria, Pakistan, Philippines, Russia, South Africa, Tajikistan, Tanzania, Ukraine, Uzbekistan, Vietnam.
Because it exhausts all available treatment options, MDR-TB is very hard to treat.
Treatment lasts two years and patients take up to 14,600 pills... and have hundreds of injections.
Treatment is successful in only 50% of cases, and causes severe side effects.
Each year, there are an estimated 450,000 new cases of MDR-TB. And until now, these patients have been ignored by pharmaceutical research.
In 2012 - 2013 there was a major development: the registration and clinical trials of two new drugs: bedaquiline and delamanid.
But two years on, fewer than 3% of patients have access to one or other of these drugs, despite their proven effectiveness
Why? Because the use of these drugs, still in the development phase, remains a long and complex process.
We still lack scientific information: how can the different drugs be combined to deliver effective treatment without causing serious side effects?
This situation is set to change, thanks to a project bringing together MSF and two partners, and funded by Unitaid.
In 4 years time, in 16 countries, 2,600 patients with MDR-TB will have access to treatment that will include the new drugs.
And clinical trials will determine which combination of drugs will deliver the best treatment.
By speeding up research, this project may provide hundreds of thousands of people access to effective treatment—the best way to stop the spread of the disease.

7:30

Drug-Resistant Tuberculosis in English (Accent from USA)

Drug-Resistant Tuberculosis in English (Accent from USA)

Drug-Resistant Tuberculosis in English (Accent from USA)

TB is a treatable disease if you follow your doctor’s treatment plan. If TB is not treated properly, TB bacteria can become resistant to one or multiple drugs used in treatment. When the bacteria become resistant to multiple drugs, it is known as multidrug-resistant tuberculosis (or MDR-TB). Treatment plans for MDR-TB involve another group of antibiotics called second-line antibiotics. These drugs vary in duration and can also have negative side effects, but they are necessary to cure MDR-TB. Work closely with your doctor or healthcare provider to develop a plan and then stick to it.
Click here to download this animation from our Video Library - https://sawbo-animations.org/video.php?video=//www.youtube.com/embed/-aDr4ZdwxBM
To donate to SAWBO please click here - https://sawbo-animations.org/donate

12:59

Multidrug-Resistant Tuberculosis (MDR-TB) - Educational Video

Multidrug-Resistant Tuberculosis (MDR-TB) - Educational Video

Multidrug-Resistant Tuberculosis (MDR-TB) - Educational Video

1:24

MDR-Tuberculosis [Part 4] TREATMENT

MDR-Tuberculosis [Part 4] TREATMENT

MDR-Tuberculosis [Part 4] TREATMENT

This is part four of the series of Multi Drug Resistant Tuberculosis, a disease that is increasing at an alarming rate. This video highlights (in a brief overview) of the Treatments of MDR-TB.

You can also visit us at http://www.satyamevjayate.in
Episode 4 of Satyamev Jayate focuses on the biggest public health problem India faces today—tuberculosis.
Through the testimonies of patients, medical experts and health workers, the episode highlights how TB should not be regarded as a poor man's disease, but one that affects every strata of society.

3:15

Fears over drug-resistant TB on the rise | DW English

Fears over drug-resistant TB on the rise | DW English

Fears over drug-resistant TB on the rise | DW English

Tuberculosis is one of the deadliest diseases in the world. While efforts to wipe it out have had some success, recently there has been a rise in drug-resistant strains. One country struggling to deal with the resurgence is Ukraine.
More DW News: http://www.dw.com/en/top-stories/s-9097

2:22

Easing Treatment for Drug-Resistant TB in Armenia

Easing Treatment for Drug-Resistant TB in Armenia

Easing Treatment for Drug-Resistant TB in Armenia

Treatment for patients with multi drug-resistant tuberculosis (MDR-TB) is long, arduous, and unpleasant. Side effects of the treatment can be difficult to endure, but patients who adhere to the treatment protocol increase their chances of recovery. In an attempt to make the lives of MDR-TB patients in Armenia easier, Doctors Without Borders/Médecins Sans Frontières (MSF) has been trying new methods of patient support.
Next, watch "Fighting Drug-Resistant TB in Swaziland": https://www.youtube.com/watch?v=HAZRrVNZg8w
Subscribe to the MSF-USA Youtube channel for videos every week on MSF's issues and activities around the world. We bring you stories from the field about emergency response during war, conflict, and natural disasters; aiding refugees; providing mother and child health care; and more. Subscribe here: https://www.youtube.com/user/MSF

3:03

Multidrug Resistant Tuberculosis - #MDR-TB

Multidrug Resistant Tuberculosis - #MDR-TB

Multidrug Resistant Tuberculosis - #MDR-TB

There are many forgotten crises in this world, and one of them is Multidrug-Resistant Tuberculosis (MDR-TB). In this video you'll see what MDR-TB has done over the last 10 years, which should make you open your eyes and realise how terrible this disease really is.
Donate to Médecins Sans Frontières (one of the organisations that helps people in poor countries suffering from MDR-TB:
http://www.msf.org/donate

What is MDR-TB?

The Eugene Bell Foundation treats North Korean patients with multidrug-resistant tuberculosis (MDR-TB), a deadly but curable disease. As the only large organization treating MDR-TB in North Korea, we are the last, best hope for hundreds of patients all across the country. Learn more about what makes MDR-TB so dangerous and how you can stop it at www.eugene-bell.org

MDR Tuberculosis and Cure - Multi Drug Resistant T.B - Health Plus

Tuberculosis is one of the most dangerous diseases. 19% of the population are facing death because of TB. Every minute one person dies because of T.B.Awareness is the best cure. Tuber in very commonly called as blockage. It is a serious infectious bacterial disease, which effects lungs. Through our presentation, know how TB is effecting people, what are the causes and effects of tuberculosis.
Careworldtv Channel is the #1 destination for Fitness & Lifestyle content on YouTube. Careworldtv helps you become a better you with how-to videos covering everything from exercise, diet, and healthy living to style, makeup, and fashion tips.
Stay tuned to watch more How to, Beauty, Health & Lifestyle videos.
Subscribe - http://www.youtube.com/subscription_center?add_user=careworldtv
Watch more...

published: 31 Mar 2017

MDR TB in India

Drug-resistant TB | Infectious diseases | NCLEX-RN | Khan Academy

Learn the different types of drug-resistant TB These videos do not provide medical advice and are for informational purposes only. The videos are not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen in any Khan Academy video. Created by Stanford School of Medicine.
Watch the next lesson: https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/tuberculosis-rn/v/tb-and-hiv?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn
Missed the previous lesson? https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseas...

published: 10 Jun 2013

Drug Resistant TB - What Should You Know

HelloEveryone!
This video features about Drug Resistant TB and What Should You Know about TB or Tuberculosis disease.
Thanks for watching! please let me know what you wanna see next.
Help Us Like & Share This Video. Don't forget to Subscribe & comment below. Thanks!
★★★★★★★★★★★★★★★★★★★
PLEASE SUBSCRIBE FOR MORE!!!
★★★★★★★★★★★★★★★★★★★
Written Updates!
Tuberculosis is one of the top 10 causes of death worldwide and India has the maximum number of cases of this deadly but curable and treatable disease. The World Health Organization’s Global Tuberculosis Report in 2016 estimates that there are 79,000 cases of MDR-TB or Multi-Drug Resistance Tuberculosis. This is becoming a serious problem and a big public health issue.
Tuberculosis is a disease caused by the bacteria Mycobacterium Tuberc...

published: 28 Mar 2017

Tackling Drug-Resistant TB

The first new TB drug in 40 years brings hope to patients. Arman is one of 450,000 people per year worldwide who are infected with a dangerous, mutated version of one of the world's deadliest diseases - tuberculosis (TB). The illness kills 1.3 million people per year, more than any other infectious disease apart from HIV/AIDS.

published: 27 May 2014

MDR TB slide show

published: 19 May 2017

A Multidrug-Resistant TB Patient's Story

This is the story of Maricel, a survivor and advocate of multidrug-resistant tuberculosis (MDR-TB).
Learn more about MDR-TB: http://www.who.int/features/qa/79/en/

published: 18 Nov 2017

Treating Pulane - MDR-TB, PIH Lesotho

A young, dangerously emaciated girl in Lesotho is examined and treated at a specialized TB facility, in an attempt to reverse her life threatening condition(s).

published: 24 Oct 2011

recover story of lady from MDR TB on Satyamev Jayate on 26th October 2014

Surviving MDR-TB: My Story, My Voice

MDR-TB Patients Speak TDF 2009.wmv

published: 24 Apr 2011

MDR-TB: Speeding up research efforts

Ignored for the past fifty years, the needs of patients suffering from tuberculosis are finally being addressed... especially for patients with a multi-drug resistant form of the disease, who can now hope to have access to effective treatments within the next few years.
So why are these new treatments needed so badly? Multi-drug resistant tuberculosis is a real killer, and a major public health issue.
Tuberculosis, or TB, is an infectious disease that is treated with antibiotics. But some bacteria have found ways to resist or fght off the drug due to incorrectly administered treatment. When the two main antibiotics stop being effective against the disease, it is labelled multi-drug resistant tuberculosis, or MDR-TB
These are the 27 worst affected countries: Armenia, Azerbaijan, Bangladesh...

published: 24 Mar 2015

Drug-Resistant Tuberculosis in English (Accent from USA)

TB is a treatable disease if you follow your doctor’s treatment plan. If TB is not treated properly, TB bacteria can become resistant to one or multiple drugs used in treatment. When the bacteria become resistant to multiple drugs, it is known as multidrug-resistant tuberculosis (or MDR-TB). Treatment plans for MDR-TB involve another group of antibiotics called second-line antibiotics. These drugs vary in duration and can also have negative side effects, but they are necessary to cure MDR-TB. Work closely with your doctor or healthcare provider to develop a plan and then stick to it.
Click here to download this animation from our Video Library - https://sawbo-animations.org/video.php?video=//www.youtube.com/embed/-aDr4ZdwxBM
To donate to SAWBO please click here - https://sawbo-animations...

published: 26 Apr 2018

Multidrug-Resistant Tuberculosis (MDR-TB) - Educational Video

published: 11 Jul 2011

MDR-Tuberculosis [Part 4] TREATMENT

This is part four of the series of Multi Drug Resistant Tuberculosis, a disease that is increasing at an alarming rate. This video highlights (in a brief overview) of the Treatments of MDR-TB.

published: 10 May 2013

MDR TB Information

You can also visit us at http://www.satyamevjayate.in
Episode 4 of Satyamev Jayate focuses on the biggest public health problem India faces today—tuberculosis.
Through the testimonies of patients, medical experts and health workers, the episode highlights how TB should not be regarded as a poor man's disease, but one that affects every strata of society.

published: 26 Oct 2014

Fears over drug-resistant TB on the rise | DW English

Tuberculosis is one of the deadliest diseases in the world. While efforts to wipe it out have had some success, recently there has been a rise in drug-resistant strains. One country struggling to deal with the resurgence is Ukraine.
More DW News: http://www.dw.com/en/top-stories/s-9097

published: 25 Mar 2018

Easing Treatment for Drug-Resistant TB in Armenia

Treatment for patients with multi drug-resistant tuberculosis (MDR-TB) is long, arduous, and unpleasant. Side effects of the treatment can be difficult to endure, but patients who adhere to the treatment protocol increase their chances of recovery. In an attempt to make the lives of MDR-TB patients in Armenia easier, Doctors Without Borders/Médecins Sans Frontières (MSF) has been trying new methods of patient support.
Next, watch "Fighting Drug-Resistant TB in Swaziland": https://www.youtube.com/watch?v=HAZRrVNZg8w
Subscribe to the MSF-USA Youtube channel for videos every week on MSF's issues and activities around the world. We bring you stories from the field about emergency response during war, conflict, and natural disasters; aiding refugees; providing mother and child health care; a...

published: 22 May 2017

Multidrug Resistant Tuberculosis - #MDR-TB

There are many forgotten crises in this world, and one of them is Multidrug-Resistant Tuberculosis (MDR-TB). In this video you'll see what MDR-TB has done over the last 10 years, which should make you open your eyes and realise how terrible this disease really is.
Donate to Médecins Sans Frontières (one of the organisations that helps people in poor countries suffering from MDR-TB:
http://www.msf.org/donate

The Eugene Bell Foundation treats North Korean patients with multidrug-resistant tuberculosis (MDR-TB), a deadly but curable disease. As the only large organization treating MDR-TB in North Korea, we are the last, best hope for hundreds of patients all across the country. Learn more about what makes MDR-TB so dangerous and how you can stop it at www.eugene-bell.org

The Eugene Bell Foundation treats North Korean patients with multidrug-resistant tuberculosis (MDR-TB), a deadly but curable disease. As the only large organization treating MDR-TB in North Korea, we are the last, best hope for hundreds of patients all across the country. Learn more about what makes MDR-TB so dangerous and how you can stop it at www.eugene-bell.org

MDR Tuberculosis and Cure - Multi Drug Resistant T.B - Health Plus

Tuberculosis is one of the most dangerous diseases. 19% of the population are facing death because of TB. Every minute one person dies because of T.B. Awarenes...

Tuberculosis is one of the most dangerous diseases. 19% of the population are facing death because of TB. Every minute one person dies because of T.B.Awareness is the best cure. Tuber in very commonly called as blockage. It is a serious infectious bacterial disease, which effects lungs. Through our presentation, know how TB is effecting people, what are the causes and effects of tuberculosis.
Careworldtv Channel is the #1 destination for Fitness & Lifestyle content on YouTube. Careworldtv helps you become a better you with how-to videos covering everything from exercise, diet, and healthy living to style, makeup, and fashion tips.
Stay tuned to watch more How to, Beauty, Health & Lifestyle videos.
Subscribe - http://www.youtube.com/subscription_center?add_user=careworldtv
Watch more amazing videos from careworldtv;
Beauty Tips - https://www.youtube.com/playlist?list=PLUG4hbjc2bbIY4IOdnjuUBOtWqMivehu1
Lifestyle Tips - https://www.youtube.com/playlist?list=PLUG4hbjc2bbIIyJko3mZcMrInwXDb7Xr6
Infertility Issues - https://www.youtube.com/playlist?list=PLUG4hbjc2bbLPPbL2WxGLsK0F6crsDmTN
Health Plus - https://www.youtube.com/playlist?list=PLUG4hbjc2bbKQG9OYRq0-4WtIJMCpjqwA
Kya Karu Mai ABB - https://www.youtube.com/playlist?list=PLUG4hbjc2bbKffKelWm5Z7_y81D-SJLYu
Fashion Tips by Gorgeous You - https://www.youtube.com/playlist?list=PLUG4hbjc2bbLQN60z7hUxhfmFyHk4Wxhx
Healthy Recipes - https://www.youtube.com/playlist?list=PLUG4hbjc2bbK_KUiNi1MCFka1xni6A1bz
Fitness Expert - https://www.youtube.com/playlist?list=PLUG4hbjc2bbK3-tsJfgX4cUnJ6nKAirqB
Wedding and bridal beauty tips - https://www.youtube.com/playlist?list=PLUG4hbjc2bbINDauWM-fUaXtBBCYFYFii

Tuberculosis is one of the most dangerous diseases. 19% of the population are facing death because of TB. Every minute one person dies because of T.B.Awareness is the best cure. Tuber in very commonly called as blockage. It is a serious infectious bacterial disease, which effects lungs. Through our presentation, know how TB is effecting people, what are the causes and effects of tuberculosis.
Careworldtv Channel is the #1 destination for Fitness & Lifestyle content on YouTube. Careworldtv helps you become a better you with how-to videos covering everything from exercise, diet, and healthy living to style, makeup, and fashion tips.
Stay tuned to watch more How to, Beauty, Health & Lifestyle videos.
Subscribe - http://www.youtube.com/subscription_center?add_user=careworldtv
Watch more amazing videos from careworldtv;
Beauty Tips - https://www.youtube.com/playlist?list=PLUG4hbjc2bbIY4IOdnjuUBOtWqMivehu1
Lifestyle Tips - https://www.youtube.com/playlist?list=PLUG4hbjc2bbIIyJko3mZcMrInwXDb7Xr6
Infertility Issues - https://www.youtube.com/playlist?list=PLUG4hbjc2bbLPPbL2WxGLsK0F6crsDmTN
Health Plus - https://www.youtube.com/playlist?list=PLUG4hbjc2bbKQG9OYRq0-4WtIJMCpjqwA
Kya Karu Mai ABB - https://www.youtube.com/playlist?list=PLUG4hbjc2bbKffKelWm5Z7_y81D-SJLYu
Fashion Tips by Gorgeous You - https://www.youtube.com/playlist?list=PLUG4hbjc2bbLQN60z7hUxhfmFyHk4Wxhx
Healthy Recipes - https://www.youtube.com/playlist?list=PLUG4hbjc2bbK_KUiNi1MCFka1xni6A1bz
Fitness Expert - https://www.youtube.com/playlist?list=PLUG4hbjc2bbK3-tsJfgX4cUnJ6nKAirqB
Wedding and bridal beauty tips - https://www.youtube.com/playlist?list=PLUG4hbjc2bbINDauWM-fUaXtBBCYFYFii

Drug-resistant TB | Infectious diseases | NCLEX-RN | Khan Academy

Learn the different types of drug-resistant TB These videos do not provide medical advice and are for informational purposes only. The videos are not intended t...

Learn the different types of drug-resistant TB These videos do not provide medical advice and are for informational purposes only. The videos are not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen in any Khan Academy video. Created by Stanford School of Medicine.
Watch the next lesson: https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/tuberculosis-rn/v/tb-and-hiv?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn
Missed the previous lesson? https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/tuberculosis-rn/v/treatment-of-active-tb?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn
NCLEX-RN on Khan Academy: A collection of questions from content covered on the NCLEX-RN. These questions are available under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0United StatesLicense (available at http://creativecommons.org/licenses/by-nc-sa/3.0/us/).
About Khan Academy: Khan Academy offers practice exercises, instructional videos, and a personalized learning dashboard that empower learners to study at their own pace in and outside of the classroom. We tackle math, science, computer programming, history, art history, economics, and more. Our math missions guide learners from kindergarten to calculus using state-of-the-art, adaptive technology that identifies strengths and learning gaps. We've also partnered with institutions like NASA, The Museum of Modern Art, The California Academy of Sciences, and MIT to offer specialized content.
For free. For everyone. Forever. #YouCanLearnAnything
Subscribe to Khan Academy’s NCLEX-RN channel: https://www.youtube.com/channel/UCDx5cTeADCvKWgF9x_Qjz3g?sub_confirmation=1
Subscribe to Khan Academy: https://www.youtube.com/subscription_center?add_user=khanacademy

Learn the different types of drug-resistant TB These videos do not provide medical advice and are for informational purposes only. The videos are not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen in any Khan Academy video. Created by Stanford School of Medicine.
Watch the next lesson: https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/tuberculosis-rn/v/tb-and-hiv?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn
Missed the previous lesson? https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/tuberculosis-rn/v/treatment-of-active-tb?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn
NCLEX-RN on Khan Academy: A collection of questions from content covered on the NCLEX-RN. These questions are available under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0United StatesLicense (available at http://creativecommons.org/licenses/by-nc-sa/3.0/us/).
About Khan Academy: Khan Academy offers practice exercises, instructional videos, and a personalized learning dashboard that empower learners to study at their own pace in and outside of the classroom. We tackle math, science, computer programming, history, art history, economics, and more. Our math missions guide learners from kindergarten to calculus using state-of-the-art, adaptive technology that identifies strengths and learning gaps. We've also partnered with institutions like NASA, The Museum of Modern Art, The California Academy of Sciences, and MIT to offer specialized content.
For free. For everyone. Forever. #YouCanLearnAnything
Subscribe to Khan Academy’s NCLEX-RN channel: https://www.youtube.com/channel/UCDx5cTeADCvKWgF9x_Qjz3g?sub_confirmation=1
Subscribe to Khan Academy: https://www.youtube.com/subscription_center?add_user=khanacademy

Drug Resistant TB - What Should You Know

HelloEveryone!
This video features about Drug Resistant TB and What Should You Know about TB or Tuberculosis disease.
Thanks for watching! please let me know ...

HelloEveryone!
This video features about Drug Resistant TB and What Should You Know about TB or Tuberculosis disease.
Thanks for watching! please let me know what you wanna see next.
Help Us Like & Share This Video. Don't forget to Subscribe & comment below. Thanks!
★★★★★★★★★★★★★★★★★★★
PLEASE SUBSCRIBE FOR MORE!!!
★★★★★★★★★★★★★★★★★★★
Written Updates!
Tuberculosis is one of the top 10 causes of death worldwide and India has the maximum number of cases of this deadly but curable and treatable disease. The World Health Organization’s Global Tuberculosis Report in 2016 estimates that there are 79,000 cases of MDR-TB or Multi-Drug Resistance Tuberculosis. This is becoming a serious problem and a big public health issue.
Tuberculosis is a disease caused by the bacteria Mycobacterium Tuberculosis. It is spread from person to person through the air. When people affected with tuberculosis sneeze, spit or cough, the bacteria goes into the air and if someone inhales these germs, they can become affected. It usually affects the lungs but can also spread to all other organs of the body.
Symptoms of tuberculosis include cough, low grade fever, night sweats or unexplained weight loss. When a person develops tuberculosis, they can have mild symptoms for many months before being detected with the infection. People affected with HIV are 20 to 30 more times likely to develop active tuberculosis.
Drug-Resistant Tuberculosis
An active case of tuberculosis usually can be treated with a standard 6 month course of 4 anti-Tb drugs. Since these medications have been used for many years, new forms of Tb that are resistant to the standard Tb drugs are being seen.
There are multiple forms of Drug Resistant Tuberculosis that includes
1. Multi Drug Resistant Tb or MDR-TB.
2. Extensively-Drug Resistant Tb or XDR-TB.
3. Extremely drug resistant TB or XXDR.
Various reasons have lead to drug resistant form of tuberculosis
1. Delays in Detection and Referral.
2. Adherence to Treatment Regimens.
3. Expensive Drug Regimens.
According to the WHO, 480,000 people were affected with MDR-TB in 2015 worldwide. In India, it is estimated that 2.5% of all new TB cases are MDR-TB.

HelloEveryone!
This video features about Drug Resistant TB and What Should You Know about TB or Tuberculosis disease.
Thanks for watching! please let me know what you wanna see next.
Help Us Like & Share This Video. Don't forget to Subscribe & comment below. Thanks!
★★★★★★★★★★★★★★★★★★★
PLEASE SUBSCRIBE FOR MORE!!!
★★★★★★★★★★★★★★★★★★★
Written Updates!
Tuberculosis is one of the top 10 causes of death worldwide and India has the maximum number of cases of this deadly but curable and treatable disease. The World Health Organization’s Global Tuberculosis Report in 2016 estimates that there are 79,000 cases of MDR-TB or Multi-Drug Resistance Tuberculosis. This is becoming a serious problem and a big public health issue.
Tuberculosis is a disease caused by the bacteria Mycobacterium Tuberculosis. It is spread from person to person through the air. When people affected with tuberculosis sneeze, spit or cough, the bacteria goes into the air and if someone inhales these germs, they can become affected. It usually affects the lungs but can also spread to all other organs of the body.
Symptoms of tuberculosis include cough, low grade fever, night sweats or unexplained weight loss. When a person develops tuberculosis, they can have mild symptoms for many months before being detected with the infection. People affected with HIV are 20 to 30 more times likely to develop active tuberculosis.
Drug-Resistant Tuberculosis
An active case of tuberculosis usually can be treated with a standard 6 month course of 4 anti-Tb drugs. Since these medications have been used for many years, new forms of Tb that are resistant to the standard Tb drugs are being seen.
There are multiple forms of Drug Resistant Tuberculosis that includes
1. Multi Drug Resistant Tb or MDR-TB.
2. Extensively-Drug Resistant Tb or XDR-TB.
3. Extremely drug resistant TB or XXDR.
Various reasons have lead to drug resistant form of tuberculosis
1. Delays in Detection and Referral.
2. Adherence to Treatment Regimens.
3. Expensive Drug Regimens.
According to the WHO, 480,000 people were affected with MDR-TB in 2015 worldwide. In India, it is estimated that 2.5% of all new TB cases are MDR-TB.

Tackling Drug-Resistant TB

The first new TB drug in 40 years brings hope to patients. Arman is one of 450,000 people per year worldwide who are infected with a dangerous, mutated version...

The first new TB drug in 40 years brings hope to patients. Arman is one of 450,000 people per year worldwide who are infected with a dangerous, mutated version of one of the world's deadliest diseases - tuberculosis (TB). The illness kills 1.3 million people per year, more than any other infectious disease apart from HIV/AIDS.

The first new TB drug in 40 years brings hope to patients. Arman is one of 450,000 people per year worldwide who are infected with a dangerous, mutated version of one of the world's deadliest diseases - tuberculosis (TB). The illness kills 1.3 million people per year, more than any other infectious disease apart from HIV/AIDS.

MDR-TB: Speeding up research efforts

Ignored for the past fifty years, the needs of patients suffering from tuberculosis are finally being addressed... especially for patients with a multi-drug res...

Ignored for the past fifty years, the needs of patients suffering from tuberculosis are finally being addressed... especially for patients with a multi-drug resistant form of the disease, who can now hope to have access to effective treatments within the next few years.
So why are these new treatments needed so badly? Multi-drug resistant tuberculosis is a real killer, and a major public health issue.
Tuberculosis, or TB, is an infectious disease that is treated with antibiotics. But some bacteria have found ways to resist or fght off the drug due to incorrectly administered treatment. When the two main antibiotics stop being effective against the disease, it is labelled multi-drug resistant tuberculosis, or MDR-TB
These are the 27 worst affected countries: Armenia, Azerbaijan, Bangladesh, Belorussia, Bulgaria, Chine, DRC, Ethiopia, Estonia, India, Indonesia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Moldavia, Myanmar, Nigeria, Pakistan, Philippines, Russia, South Africa, Tajikistan, Tanzania, Ukraine, Uzbekistan, Vietnam.
Because it exhausts all available treatment options, MDR-TB is very hard to treat.
Treatment lasts two years and patients take up to 14,600 pills... and have hundreds of injections.
Treatment is successful in only 50% of cases, and causes severe side effects.
Each year, there are an estimated 450,000 new cases of MDR-TB. And until now, these patients have been ignored by pharmaceutical research.
In 2012 - 2013 there was a major development: the registration and clinical trials of two new drugs: bedaquiline and delamanid.
But two years on, fewer than 3% of patients have access to one or other of these drugs, despite their proven effectiveness
Why? Because the use of these drugs, still in the development phase, remains a long and complex process.
We still lack scientific information: how can the different drugs be combined to deliver effective treatment without causing serious side effects?
This situation is set to change, thanks to a project bringing together MSF and two partners, and funded by Unitaid.
In 4 years time, in 16 countries, 2,600 patients with MDR-TB will have access to treatment that will include the new drugs.
And clinical trials will determine which combination of drugs will deliver the best treatment.
By speeding up research, this project may provide hundreds of thousands of people access to effective treatment—the best way to stop the spread of the disease.

Ignored for the past fifty years, the needs of patients suffering from tuberculosis are finally being addressed... especially for patients with a multi-drug resistant form of the disease, who can now hope to have access to effective treatments within the next few years.
So why are these new treatments needed so badly? Multi-drug resistant tuberculosis is a real killer, and a major public health issue.
Tuberculosis, or TB, is an infectious disease that is treated with antibiotics. But some bacteria have found ways to resist or fght off the drug due to incorrectly administered treatment. When the two main antibiotics stop being effective against the disease, it is labelled multi-drug resistant tuberculosis, or MDR-TB
These are the 27 worst affected countries: Armenia, Azerbaijan, Bangladesh, Belorussia, Bulgaria, Chine, DRC, Ethiopia, Estonia, India, Indonesia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Moldavia, Myanmar, Nigeria, Pakistan, Philippines, Russia, South Africa, Tajikistan, Tanzania, Ukraine, Uzbekistan, Vietnam.
Because it exhausts all available treatment options, MDR-TB is very hard to treat.
Treatment lasts two years and patients take up to 14,600 pills... and have hundreds of injections.
Treatment is successful in only 50% of cases, and causes severe side effects.
Each year, there are an estimated 450,000 new cases of MDR-TB. And until now, these patients have been ignored by pharmaceutical research.
In 2012 - 2013 there was a major development: the registration and clinical trials of two new drugs: bedaquiline and delamanid.
But two years on, fewer than 3% of patients have access to one or other of these drugs, despite their proven effectiveness
Why? Because the use of these drugs, still in the development phase, remains a long and complex process.
We still lack scientific information: how can the different drugs be combined to deliver effective treatment without causing serious side effects?
This situation is set to change, thanks to a project bringing together MSF and two partners, and funded by Unitaid.
In 4 years time, in 16 countries, 2,600 patients with MDR-TB will have access to treatment that will include the new drugs.
And clinical trials will determine which combination of drugs will deliver the best treatment.
By speeding up research, this project may provide hundreds of thousands of people access to effective treatment—the best way to stop the spread of the disease.

Drug-Resistant Tuberculosis in English (Accent from USA)

TB is a treatable disease if you follow your doctor’s treatment plan. If TB is not treated properly, TB bacteria can become resistant to one or multiple drugs u...

TB is a treatable disease if you follow your doctor’s treatment plan. If TB is not treated properly, TB bacteria can become resistant to one or multiple drugs used in treatment. When the bacteria become resistant to multiple drugs, it is known as multidrug-resistant tuberculosis (or MDR-TB). Treatment plans for MDR-TB involve another group of antibiotics called second-line antibiotics. These drugs vary in duration and can also have negative side effects, but they are necessary to cure MDR-TB. Work closely with your doctor or healthcare provider to develop a plan and then stick to it.
Click here to download this animation from our Video Library - https://sawbo-animations.org/video.php?video=//www.youtube.com/embed/-aDr4ZdwxBM
To donate to SAWBO please click here - https://sawbo-animations.org/donate

TB is a treatable disease if you follow your doctor’s treatment plan. If TB is not treated properly, TB bacteria can become resistant to one or multiple drugs used in treatment. When the bacteria become resistant to multiple drugs, it is known as multidrug-resistant tuberculosis (or MDR-TB). Treatment plans for MDR-TB involve another group of antibiotics called second-line antibiotics. These drugs vary in duration and can also have negative side effects, but they are necessary to cure MDR-TB. Work closely with your doctor or healthcare provider to develop a plan and then stick to it.
Click here to download this animation from our Video Library - https://sawbo-animations.org/video.php?video=//www.youtube.com/embed/-aDr4ZdwxBM
To donate to SAWBO please click here - https://sawbo-animations.org/donate

You can also visit us at http://www.satyamevjayate.in
Episode 4 of Satyamev Jayate focuses on the biggest public health problem India faces today—tuberculosis.
Through the testimonies of patients, medical experts and health workers, the episode highlights how TB should not be regarded as a poor man's disease, but one that affects every strata of society.

You can also visit us at http://www.satyamevjayate.in
Episode 4 of Satyamev Jayate focuses on the biggest public health problem India faces today—tuberculosis.
Through the testimonies of patients, medical experts and health workers, the episode highlights how TB should not be regarded as a poor man's disease, but one that affects every strata of society.

Fears over drug-resistant TB on the rise | DW English

Tuberculosis is one of the deadliest diseases in the world. While efforts to wipe it out have had some success, recently there has been a rise in drug-resistant...

Tuberculosis is one of the deadliest diseases in the world. While efforts to wipe it out have had some success, recently there has been a rise in drug-resistant strains. One country struggling to deal with the resurgence is Ukraine.
More DW News: http://www.dw.com/en/top-stories/s-9097

Tuberculosis is one of the deadliest diseases in the world. While efforts to wipe it out have had some success, recently there has been a rise in drug-resistant strains. One country struggling to deal with the resurgence is Ukraine.
More DW News: http://www.dw.com/en/top-stories/s-9097

Easing Treatment for Drug-Resistant TB in Armenia

Treatment for patients with multi drug-resistant tuberculosis (MDR-TB) is long, arduous, and unpleasant. Side effects of the treatment can be difficult to endur...

Treatment for patients with multi drug-resistant tuberculosis (MDR-TB) is long, arduous, and unpleasant. Side effects of the treatment can be difficult to endure, but patients who adhere to the treatment protocol increase their chances of recovery. In an attempt to make the lives of MDR-TB patients in Armenia easier, Doctors Without Borders/Médecins Sans Frontières (MSF) has been trying new methods of patient support.
Next, watch "Fighting Drug-Resistant TB in Swaziland": https://www.youtube.com/watch?v=HAZRrVNZg8w
Subscribe to the MSF-USA Youtube channel for videos every week on MSF's issues and activities around the world. We bring you stories from the field about emergency response during war, conflict, and natural disasters; aiding refugees; providing mother and child health care; and more. Subscribe here: https://www.youtube.com/user/MSF

Treatment for patients with multi drug-resistant tuberculosis (MDR-TB) is long, arduous, and unpleasant. Side effects of the treatment can be difficult to endure, but patients who adhere to the treatment protocol increase their chances of recovery. In an attempt to make the lives of MDR-TB patients in Armenia easier, Doctors Without Borders/Médecins Sans Frontières (MSF) has been trying new methods of patient support.
Next, watch "Fighting Drug-Resistant TB in Swaziland": https://www.youtube.com/watch?v=HAZRrVNZg8w
Subscribe to the MSF-USA Youtube channel for videos every week on MSF's issues and activities around the world. We bring you stories from the field about emergency response during war, conflict, and natural disasters; aiding refugees; providing mother and child health care; and more. Subscribe here: https://www.youtube.com/user/MSF

Multidrug Resistant Tuberculosis - #MDR-TB

There are many forgotten crises in this world, and one of them is Multidrug-Resistant Tuberculosis (MDR-TB). In this video you'll see what MDR-TB has done over ...

There are many forgotten crises in this world, and one of them is Multidrug-Resistant Tuberculosis (MDR-TB). In this video you'll see what MDR-TB has done over the last 10 years, which should make you open your eyes and realise how terrible this disease really is.
Donate to Médecins Sans Frontières (one of the organisations that helps people in poor countries suffering from MDR-TB:
http://www.msf.org/donate

There are many forgotten crises in this world, and one of them is Multidrug-Resistant Tuberculosis (MDR-TB). In this video you'll see what MDR-TB has done over the last 10 years, which should make you open your eyes and realise how terrible this disease really is.
Donate to Médecins Sans Frontières (one of the organisations that helps people in poor countries suffering from MDR-TB:
http://www.msf.org/donate

You can also visit us at http://www.satyamevjayate.in
Episode 4 of Satyamev Jayate focuses on the biggest public health problem India faces today—tuberculosis.
Through the testimonies of patients, medical experts and health workers, the episode highlights how TB should not be regarded as a poor man's disease, but one that affects every strata of society.

🇮🇳 India | Tuberculosis: Contagion | 101 East

Tuberculosis (TB) is a centuries-old disease that many believe is now relegated to the slums of impoverished countries in Africa and Asia.
But while developing countries bear the brunt of new infections, TB is still one of the world's deadliest illnesses, killing 1.4 million people in 2011 alone. One out of every three people alive today carries Mycobacterium Tuberculosis, the germ that causes the illness.
"There's no question that if you're poor, then you're much more likely to have tuberculosis. But because TB is an airborne disease, TB anywhere is TB everywhere," says Dr Peter Small from the Bill and Melinda Gates Foundation.
The disease is most infectious in congested communities with poor access to quality nutrition and hygiene, conditions that are rife in India.
It spreads throu...

Pathogenesis of TB and MDRTB

Dr IraShah explain to us in details about the Pathogenesis of TB and MDRTB relating to the newer studies and updates in 2014.
The lecture starts with explanation of TB, its transmission and pathogenesis. Then theres detailed explanation on DR, MDR, XDR TB along with its treatment, outcome and problems faced.
-~-~~-~~~-~~-~-
Please watch: "Dr. Rakesh Kumar : About India's VaccineScenario | pediatric Oncall "
https://www.youtube.com/watch?v=UVn6k5moI2s
-~-~~-~~~-~~-~-

MDRTB - Dr Rajagopal

published: 12 Jul 2015

Second line medications for MDR-TB treatment; new drugs in the pipeline

This lecture by Dr. Carole Mitnick (Harvard Medical School and Partners In Health) includes information on second-line medications for TB, their pharmacological characteristics, MBT targets and dosages, and drugs in development. This lecture was recorded in July 2012.

published: 07 Apr 2014

Managing injectable drugs in children treated for MDR-TB

This webinar, recorded on April 29, 2015 and organized in partnership with the SentinelProject, covers the following topics:
- Rreview the use of second-line injectables for children with MDR-TB, including current international recommendations, choice of drug, duration of treatment, and adverse effects;
- Discuss safe and age-appropriate intramuscular injection in children;
- Review key aspects of age-appropriate audiology assessment in children treated with second-line injectables, and discuss how to respond to ototoxicity;
- Highlight future approaches to limiting the adverse effects associated with second-line injectables in children.
Presented by Dr. Tony Garcia-Prats, Ms. Ann Raftery and Ms. Kayleen Jacobs.
The Sentinel Project on Pediatric Drug-Resistant Tuberculosis is a glob...

You can also visit us at http://www.satyamevjayate.in
Episode 4 of Satyamev Jayate focuses on the biggest public health problem India faces today—tuberculosis.
Through the testimonies of patients, medical experts and health workers, the episode highlights how TB should not be regarded as a poor man's disease, but one that affects every strata of society.

You can also visit us at http://www.satyamevjayate.in
Episode 4 of Satyamev Jayate focuses on the biggest public health problem India faces today—tuberculosis.
Through the testimonies of patients, medical experts and health workers, the episode highlights how TB should not be regarded as a poor man's disease, but one that affects every strata of society.

🇮🇳 India | Tuberculosis: Contagion | 101 East

Tuberculosis (TB) is a centuries-old disease that many believe is now relegated to the slums of impoverished countries in Africa and Asia.
But while developing...

Tuberculosis (TB) is a centuries-old disease that many believe is now relegated to the slums of impoverished countries in Africa and Asia.
But while developing countries bear the brunt of new infections, TB is still one of the world's deadliest illnesses, killing 1.4 million people in 2011 alone. One out of every three people alive today carries Mycobacterium Tuberculosis, the germ that causes the illness.
"There's no question that if you're poor, then you're much more likely to have tuberculosis. But because TB is an airborne disease, TB anywhere is TB everywhere," says Dr Peter Small from the Bill and Melinda Gates Foundation.
The disease is most infectious in congested communities with poor access to quality nutrition and hygiene, conditions that are rife in India.
It spreads through microscopic droplets from a TB-infected patient's cough that travel through the atmosphere and can be inhaled by anyone in the vicinity.
Once inside the body, the immune system walls off the bacteria to prevent it from multiplying. And that is where it lays waiting, sometimes for decades or even a lifetime, until the perfect opportunity arises.
When the immune system of a TB-infected person becomes compromised through stress, an illness like HIV or malnutrition, the bacteria seizes the moment and multiplies, usually in the lungs. It then moves through the body via the blood stream.
If left untreated, a patient slowly loses weight, suffers from chills and fevers, and ultimately dies, after potentially infecting up to 15 more people.
For the past 40 years, the same medicines has been used to treat TB. As recommended by the World Health Organisation (WHO), patients are given a first line cocktail of drugs for about six months. If they fail to respond, a second more aggressive line of treatment begins - a gruelling two-year regime of combination medication including injections. But what happens when the strongest treatments for TB fails to cure the patient?
That is the predicament that faced Dr Zarir Udwadia and his colleagues at Mumbai's Hinduja Hospital. They were baffled by a number of patients whose laboratory tests showed resistance to all 12 drugs then used to treat the illness - patients they described as infected with a 'Totally Drug Resistant (TDR)' strain of the bacteria.
"The first patient I will never forget because she was a lady who came to us from Uttar Pradesh (State). She trekked across two major states in India at distances 1000km apart. Think about how soul-destroying it must be to have five years of treatment with multiple providers - private practise, public practise -and find that you're getting worse, not better." says Dr Udwadia.
But when the Mumbai doctors flagged the problem, the government rejected their findings. They accused the doctors of being alarmist and raised questions about the quality of their laboratory. The WHO also refused to recognise the term TDR, arguing that the patients may respond to any new drugs released in the market.
But privately, health workers admit that drug resistant strains of TB are spreading in India.
The WHO estimates there are 66,000 cases of multi-drug resistant TB nationwide but the real figure could be much higher because people are being misdiagnosed with illnesses like typhoid, malaria and standard TB before doctors realise they have a drug-resistant strain of the disease.
This forces doctors to play a dangerous guessing game when treating people because if a patient has drug-resistant TB from the beginning, treatment for anything else may help strengthen the bacteria.
But beyond the science of the illness, India is paying a heavy human cost because of this contagion. The poorest are worst affected, but they are also the least equipped to deal with the devastating impact of the disease.
"Each story is heart-breaking really because these are the young bread-earners of their families. I tear up in my eyes when I talk about it because many of them are going to die, they're going to pass it onto their wives and their children," says Dr Udwadia from Hinduja Hospital in Mumbai.
"They incur huge bills just trying to cure themselves of this problem. They run from pillar to post trying to get treatment, drugs are in short supply and not easily available. And I've seen entire families devastated, wiped out, bankrupt, selling their few poultry, jewellery, [and] properties, in a desperate attempt to cure themselves of this TB."
More from 101 East on:
YouTube - http://aje.io/101eastYouTube
Facebook - http://facebook.com/101east
Twitter - http://twitter.com/aj101east
Instagram - http://instagram.com/aj101east
Website - http://aljazeera.com/101east

Tuberculosis (TB) is a centuries-old disease that many believe is now relegated to the slums of impoverished countries in Africa and Asia.
But while developing countries bear the brunt of new infections, TB is still one of the world's deadliest illnesses, killing 1.4 million people in 2011 alone. One out of every three people alive today carries Mycobacterium Tuberculosis, the germ that causes the illness.
"There's no question that if you're poor, then you're much more likely to have tuberculosis. But because TB is an airborne disease, TB anywhere is TB everywhere," says Dr Peter Small from the Bill and Melinda Gates Foundation.
The disease is most infectious in congested communities with poor access to quality nutrition and hygiene, conditions that are rife in India.
It spreads through microscopic droplets from a TB-infected patient's cough that travel through the atmosphere and can be inhaled by anyone in the vicinity.
Once inside the body, the immune system walls off the bacteria to prevent it from multiplying. And that is where it lays waiting, sometimes for decades or even a lifetime, until the perfect opportunity arises.
When the immune system of a TB-infected person becomes compromised through stress, an illness like HIV or malnutrition, the bacteria seizes the moment and multiplies, usually in the lungs. It then moves through the body via the blood stream.
If left untreated, a patient slowly loses weight, suffers from chills and fevers, and ultimately dies, after potentially infecting up to 15 more people.
For the past 40 years, the same medicines has been used to treat TB. As recommended by the World Health Organisation (WHO), patients are given a first line cocktail of drugs for about six months. If they fail to respond, a second more aggressive line of treatment begins - a gruelling two-year regime of combination medication including injections. But what happens when the strongest treatments for TB fails to cure the patient?
That is the predicament that faced Dr Zarir Udwadia and his colleagues at Mumbai's Hinduja Hospital. They were baffled by a number of patients whose laboratory tests showed resistance to all 12 drugs then used to treat the illness - patients they described as infected with a 'Totally Drug Resistant (TDR)' strain of the bacteria.
"The first patient I will never forget because she was a lady who came to us from Uttar Pradesh (State). She trekked across two major states in India at distances 1000km apart. Think about how soul-destroying it must be to have five years of treatment with multiple providers - private practise, public practise -and find that you're getting worse, not better." says Dr Udwadia.
But when the Mumbai doctors flagged the problem, the government rejected their findings. They accused the doctors of being alarmist and raised questions about the quality of their laboratory. The WHO also refused to recognise the term TDR, arguing that the patients may respond to any new drugs released in the market.
But privately, health workers admit that drug resistant strains of TB are spreading in India.
The WHO estimates there are 66,000 cases of multi-drug resistant TB nationwide but the real figure could be much higher because people are being misdiagnosed with illnesses like typhoid, malaria and standard TB before doctors realise they have a drug-resistant strain of the disease.
This forces doctors to play a dangerous guessing game when treating people because if a patient has drug-resistant TB from the beginning, treatment for anything else may help strengthen the bacteria.
But beyond the science of the illness, India is paying a heavy human cost because of this contagion. The poorest are worst affected, but they are also the least equipped to deal with the devastating impact of the disease.
"Each story is heart-breaking really because these are the young bread-earners of their families. I tear up in my eyes when I talk about it because many of them are going to die, they're going to pass it onto their wives and their children," says Dr Udwadia from Hinduja Hospital in Mumbai.
"They incur huge bills just trying to cure themselves of this problem. They run from pillar to post trying to get treatment, drugs are in short supply and not easily available. And I've seen entire families devastated, wiped out, bankrupt, selling their few poultry, jewellery, [and] properties, in a desperate attempt to cure themselves of this TB."
More from 101 East on:
YouTube - http://aje.io/101eastYouTube
Facebook - http://facebook.com/101east
Twitter - http://twitter.com/aj101east
Instagram - http://instagram.com/aj101east
Website - http://aljazeera.com/101east

Pathogenesis of TB and MDRTB

Dr IraShah explain to us in details about the Pathogenesis of TB and MDRTB relating to the newer studies and updates in 2014.
The lecture starts with explanati...

Dr IraShah explain to us in details about the Pathogenesis of TB and MDRTB relating to the newer studies and updates in 2014.
The lecture starts with explanation of TB, its transmission and pathogenesis. Then theres detailed explanation on DR, MDR, XDR TB along with its treatment, outcome and problems faced.
-~-~~-~~~-~~-~-
Please watch: "Dr. Rakesh Kumar : About India's VaccineScenario | pediatric Oncall "
https://www.youtube.com/watch?v=UVn6k5moI2s
-~-~~-~~~-~~-~-

Dr IraShah explain to us in details about the Pathogenesis of TB and MDRTB relating to the newer studies and updates in 2014.
The lecture starts with explanation of TB, its transmission and pathogenesis. Then theres detailed explanation on DR, MDR, XDR TB along with its treatment, outcome and problems faced.
-~-~~-~~~-~~-~-
Please watch: "Dr. Rakesh Kumar : About India's VaccineScenario | pediatric Oncall "
https://www.youtube.com/watch?v=UVn6k5moI2s
-~-~~-~~~-~~-~-

This lecture by Dr. Carole Mitnick (Harvard Medical School and Partners In Health) includes information on second-line medications for TB, their pharmacological characteristics, MBT targets and dosages, and drugs in development. This lecture was recorded in July 2012.

This lecture by Dr. Carole Mitnick (Harvard Medical School and Partners In Health) includes information on second-line medications for TB, their pharmacological characteristics, MBT targets and dosages, and drugs in development. This lecture was recorded in July 2012.

Managing injectable drugs in children treated for MDR-TB

This webinar, recorded on April 29, 2015 and organized in partnership with the SentinelProject, covers the following topics:
- Rreview the use of second-line ...

This webinar, recorded on April 29, 2015 and organized in partnership with the SentinelProject, covers the following topics:
- Rreview the use of second-line injectables for children with MDR-TB, including current international recommendations, choice of drug, duration of treatment, and adverse effects;
- Discuss safe and age-appropriate intramuscular injection in children;
- Review key aspects of age-appropriate audiology assessment in children treated with second-line injectables, and discuss how to respond to ototoxicity;
- Highlight future approaches to limiting the adverse effects associated with second-line injectables in children.
Presented by Dr. Tony Garcia-Prats, Ms. Ann Raftery and Ms. Kayleen Jacobs.
The Sentinel Project on Pediatric Drug-Resistant Tuberculosis is a global partnership of researchers, caregivers, and advocates who share a vision of a world where no child dies from this curable disease. Members collaborate to raise the visibility of this vulnerable population of children, and to share evidence and resources that can increase children’s access to prompt and effective treatment. For more information and to join this network, please visit www.sentinel-project.org

This webinar, recorded on April 29, 2015 and organized in partnership with the SentinelProject, covers the following topics:
- Rreview the use of second-line injectables for children with MDR-TB, including current international recommendations, choice of drug, duration of treatment, and adverse effects;
- Discuss safe and age-appropriate intramuscular injection in children;
- Review key aspects of age-appropriate audiology assessment in children treated with second-line injectables, and discuss how to respond to ototoxicity;
- Highlight future approaches to limiting the adverse effects associated with second-line injectables in children.
Presented by Dr. Tony Garcia-Prats, Ms. Ann Raftery and Ms. Kayleen Jacobs.
The Sentinel Project on Pediatric Drug-Resistant Tuberculosis is a global partnership of researchers, caregivers, and advocates who share a vision of a world where no child dies from this curable disease. Members collaborate to raise the visibility of this vulnerable population of children, and to share evidence and resources that can increase children’s access to prompt and effective treatment. For more information and to join this network, please visit www.sentinel-project.org

What is MDR-TB?

The Eugene Bell Foundation treats North Korean patients with multidrug-resistant tuberculosis (MDR-TB), a deadly but curable disease. As the only large organization treating MDR-TB in North Korea, we are the last, best hope for hundreds of patients all across the country. Learn more about what makes MDR-TB so dangerous and how you can stop it at www.eugene-bell.org

MDR Tuberculosis and Cure - Multi Drug Resistant T.B - Health Plus

Tuberculosis is one of the most dangerous diseases. 19% of the population are facing death because of TB. Every minute one person dies because of T.B.Awareness is the best cure. Tuber in very commonly called as blockage. It is a serious infectious bacterial disease, which effects lungs. Through our presentation, know how TB is effecting people, what are the causes and effects of tuberculosis.
Careworldtv Channel is the #1 destination for Fitness & Lifestyle content on YouTube. Careworldtv helps you become a better you with how-to videos covering everything from exercise, diet, and healthy living to style, makeup, and fashion tips.
Stay tuned to watch more How to, Beauty, Health & Lifestyle videos.
Subscribe - http://www.youtube.com/subscription_center?add_user=careworldtv
Watch more amazing videos from careworldtv;
Beauty Tips - https://www.youtube.com/playlist?list=PLUG4hbjc2bbIY4IOdnjuUBOtWqMivehu1
Lifestyle Tips - https://www.youtube.com/playlist?list=PLUG4hbjc2bbIIyJko3mZcMrInwXDb7Xr6
Infertility Issues - https://www.youtube.com/playlist?list=PLUG4hbjc2bbLPPbL2WxGLsK0F6crsDmTN
Health Plus - https://www.youtube.com/playlist?list=PLUG4hbjc2bbKQG9OYRq0-4WtIJMCpjqwA
Kya Karu Mai ABB - https://www.youtube.com/playlist?list=PLUG4hbjc2bbKffKelWm5Z7_y81D-SJLYu
Fashion Tips by Gorgeous You - https://www.youtube.com/playlist?list=PLUG4hbjc2bbLQN60z7hUxhfmFyHk4Wxhx
Healthy Recipes - https://www.youtube.com/playlist?list=PLUG4hbjc2bbK_KUiNi1MCFka1xni6A1bz
Fitness Expert - https://www.youtube.com/playlist?list=PLUG4hbjc2bbK3-tsJfgX4cUnJ6nKAirqB
Wedding and bridal beauty tips - https://www.youtube.com/playlist?list=PLUG4hbjc2bbINDauWM-fUaXtBBCYFYFii

Drug-resistant TB | Infectious diseases | NCLEX-RN | Khan Academy

Learn the different types of drug-resistant TB These videos do not provide medical advice and are for informational purposes only. The videos are not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen in any Khan Academy video. Created by Stanford School of Medicine.
Watch the next lesson: https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/tuberculosis-rn/v/tb-and-hiv?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn
Missed the previous lesson? https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/tuberculosis-rn/v/treatment-of-active-tb?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn
NCLEX-RN on Khan Academy: A collection of questions from content covered on the NCLEX-RN. These questions are available under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0United StatesLicense (available at http://creativecommons.org/licenses/by-nc-sa/3.0/us/).
About Khan Academy: Khan Academy offers practice exercises, instructional videos, and a personalized learning dashboard that empower learners to study at their own pace in and outside of the classroom. We tackle math, science, computer programming, history, art history, economics, and more. Our math missions guide learners from kindergarten to calculus using state-of-the-art, adaptive technology that identifies strengths and learning gaps. We've also partnered with institutions like NASA, The Museum of Modern Art, The California Academy of Sciences, and MIT to offer specialized content.
For free. For everyone. Forever. #YouCanLearnAnything
Subscribe to Khan Academy’s NCLEX-RN channel: https://www.youtube.com/channel/UCDx5cTeADCvKWgF9x_Qjz3g?sub_confirmation=1
Subscribe to Khan Academy: https://www.youtube.com/subscription_center?add_user=khanacademy

3:17

Drug Resistant TB - What Should You Know

Hello Everyone!
This video features about Drug Resistant TB and What Should You Know about...

Drug Resistant TB - What Should You Know

HelloEveryone!
This video features about Drug Resistant TB and What Should You Know about TB or Tuberculosis disease.
Thanks for watching! please let me know what you wanna see next.
Help Us Like & Share This Video. Don't forget to Subscribe & comment below. Thanks!
★★★★★★★★★★★★★★★★★★★
PLEASE SUBSCRIBE FOR MORE!!!
★★★★★★★★★★★★★★★★★★★
Written Updates!
Tuberculosis is one of the top 10 causes of death worldwide and India has the maximum number of cases of this deadly but curable and treatable disease. The World Health Organization’s Global Tuberculosis Report in 2016 estimates that there are 79,000 cases of MDR-TB or Multi-Drug Resistance Tuberculosis. This is becoming a serious problem and a big public health issue.
Tuberculosis is a disease caused by the bacteria Mycobacterium Tuberculosis. It is spread from person to person through the air. When people affected with tuberculosis sneeze, spit or cough, the bacteria goes into the air and if someone inhales these germs, they can become affected. It usually affects the lungs but can also spread to all other organs of the body.
Symptoms of tuberculosis include cough, low grade fever, night sweats or unexplained weight loss. When a person develops tuberculosis, they can have mild symptoms for many months before being detected with the infection. People affected with HIV are 20 to 30 more times likely to develop active tuberculosis.
Drug-Resistant Tuberculosis
An active case of tuberculosis usually can be treated with a standard 6 month course of 4 anti-Tb drugs. Since these medications have been used for many years, new forms of Tb that are resistant to the standard Tb drugs are being seen.
There are multiple forms of Drug Resistant Tuberculosis that includes
1. Multi Drug Resistant Tb or MDR-TB.
2. Extensively-Drug Resistant Tb or XDR-TB.
3. Extremely drug resistant TB or XXDR.
Various reasons have lead to drug resistant form of tuberculosis
1. Delays in Detection and Referral.
2. Adherence to Treatment Regimens.
3. Expensive Drug Regimens.
According to the WHO, 480,000 people were affected with MDR-TB in 2015 worldwide. In India, it is estimated that 2.5% of all new TB cases are MDR-TB.

10:27

Tackling Drug-Resistant TB

The first new TB drug in 40 years brings hope to patients. Arman is one of 450,000 people...

Tackling Drug-Resistant TB

The first new TB drug in 40 years brings hope to patients. Arman is one of 450,000 people per year worldwide who are infected with a dangerous, mutated version of one of the world's deadliest diseases - tuberculosis (TB). The illness kills 1.3 million people per year, more than any other infectious disease apart from HIV/AIDS.

Treating Pulane - MDR-TB, PIH Lesotho

A young, dangerously emaciated girl in Lesotho is examined and treated at a specialized TB facility, in an attempt to reverse her life threatening condition(s).

Multi-drug-resistant tuberculosis

Multi-drug-resistant tuberculosis (MDR-TB, also known as Vank's Disease) is defined as a form of TB infection caused by bacteria that are resistant to treatment with at least two of the most powerful first-lineanti-TB drugs,isoniazid (INH) and rifampicin (RMP).

Five percent (5%) of all TB cases across the globe in 2013 were estimated to be MDR-TB cases, including 3.5% of newly diagnosed TB cases, and 20.5% of previously treated TB cases. While rates of MDR-TB infections are relatively low in North America and Western Europe, they are an increasingly serious problem worldwide, in particular in areas of the Russian Federation, the former Soviet Union and other parts of Asia.

MDR-TB infection may be classified as either primary or acquired. Primary MDR-TB occurs in patients who have not previously been infected with TB but who become infected with a strain that is resistant to treatment. Acquired MDR-TB occurs in patients during treatment with a drug regimen that is not effective at killing the particular strain of TB with which they have been infected. Rates of primary MDR-TB are low in North America and Western Europe: in the US in 2000, the rate of primary MDR-TB was 1% of all cases of TB nationally. Most cases of acquired MDR-TB are due to inappropriate treatment with a single anti-TB drug, usually INH. This can occur due to a medical provider, such as a doctor or nurse, improperly prescribing ineffective treatment, but may also be due to the patient not taking the medication correctly, which can be due to a variety of reasons, including expense or scarcity of medicines, patient forgetfulness, or patient stopping treatment early because they feel better.

India aims to win its war on TB by 2025, but the goal seems too far-fetched ... A Call to ActionAgainstChildTB’, stated that less than 2% of the 3.6 lakh children with latent TB in India who are eligible for preventive therapy as per WHO guidelines actually got it ... Additionally, Dr Singhal said the absence of child-friendly formulations, mainly those to treat MDR-TB, add to the challenges to treat childhood TB....

The report, released by international voluntary scientific organisation The Union, shows that only 1.84 per cent of children, aged up to 14, in India receive preventive TB treatment ... The burden of multi drug-resistant TB (MDR-TB) in children is still largely unknown, but it is estimated that less than 10 per cent of all children with MDR-TB are detected and treated,” the report said....

You can also visit us at http://www.satyamevjayate.in
Episode 4 of Satyamev Jayate focuses on the biggest public health problem India faces today—tuberculosis.
Through the testimonies of patients, medical experts and health workers, the episode highlights how TB should not be regarded as a poor man's disease, but one that affects every strata of society.

🇮🇳 India | Tuberculosis: Contagion | 101 East

Tuberculosis (TB) is a centuries-old disease that many believe is now relegated to the slums of impoverished countries in Africa and Asia.
But while developing countries bear the brunt of new infections, TB is still one of the world's deadliest illnesses, killing 1.4 million people in 2011 alone. One out of every three people alive today carries Mycobacterium Tuberculosis, the germ that causes the illness.
"There's no question that if you're poor, then you're much more likely to have tuberculosis. But because TB is an airborne disease, TB anywhere is TB everywhere," says Dr Peter Small from the Bill and Melinda Gates Foundation.
The disease is most infectious in congested communities with poor access to quality nutrition and hygiene, conditions that are rife in India.
It spreads through microscopic droplets from a TB-infected patient's cough that travel through the atmosphere and can be inhaled by anyone in the vicinity.
Once inside the body, the immune system walls off the bacteria to prevent it from multiplying. And that is where it lays waiting, sometimes for decades or even a lifetime, until the perfect opportunity arises.
When the immune system of a TB-infected person becomes compromised through stress, an illness like HIV or malnutrition, the bacteria seizes the moment and multiplies, usually in the lungs. It then moves through the body via the blood stream.
If left untreated, a patient slowly loses weight, suffers from chills and fevers, and ultimately dies, after potentially infecting up to 15 more people.
For the past 40 years, the same medicines has been used to treat TB. As recommended by the World Health Organisation (WHO), patients are given a first line cocktail of drugs for about six months. If they fail to respond, a second more aggressive line of treatment begins - a gruelling two-year regime of combination medication including injections. But what happens when the strongest treatments for TB fails to cure the patient?
That is the predicament that faced Dr Zarir Udwadia and his colleagues at Mumbai's Hinduja Hospital. They were baffled by a number of patients whose laboratory tests showed resistance to all 12 drugs then used to treat the illness - patients they described as infected with a 'Totally Drug Resistant (TDR)' strain of the bacteria.
"The first patient I will never forget because she was a lady who came to us from Uttar Pradesh (State). She trekked across two major states in India at distances 1000km apart. Think about how soul-destroying it must be to have five years of treatment with multiple providers - private practise, public practise -and find that you're getting worse, not better." says Dr Udwadia.
But when the Mumbai doctors flagged the problem, the government rejected their findings. They accused the doctors of being alarmist and raised questions about the quality of their laboratory. The WHO also refused to recognise the term TDR, arguing that the patients may respond to any new drugs released in the market.
But privately, health workers admit that drug resistant strains of TB are spreading in India.
The WHO estimates there are 66,000 cases of multi-drug resistant TB nationwide but the real figure could be much higher because people are being misdiagnosed with illnesses like typhoid, malaria and standard TB before doctors realise they have a drug-resistant strain of the disease.
This forces doctors to play a dangerous guessing game when treating people because if a patient has drug-resistant TB from the beginning, treatment for anything else may help strengthen the bacteria.
But beyond the science of the illness, India is paying a heavy human cost because of this contagion. The poorest are worst affected, but they are also the least equipped to deal with the devastating impact of the disease.
"Each story is heart-breaking really because these are the young bread-earners of their families. I tear up in my eyes when I talk about it because many of them are going to die, they're going to pass it onto their wives and their children," says Dr Udwadia from Hinduja Hospital in Mumbai.
"They incur huge bills just trying to cure themselves of this problem. They run from pillar to post trying to get treatment, drugs are in short supply and not easily available. And I've seen entire families devastated, wiped out, bankrupt, selling their few poultry, jewellery, [and] properties, in a desperate attempt to cure themselves of this TB."
More from 101 East on:
YouTube - http://aje.io/101eastYouTube
Facebook - http://facebook.com/101east
Twitter - http://twitter.com/aj101east
Instagram - http://instagram.com/aj101east
Website - http://aljazeera.com/101east

Pathogenesis of TB and MDRTB

Dr IraShah explain to us in details about the Pathogenesis of TB and MDRTB relating to the newer studies and updates in 2014.
The lecture starts with explanation of TB, its transmission and pathogenesis. Then theres detailed explanation on DR, MDR, XDR TB along with its treatment, outcome and problems faced.
-~-~~-~~~-~~-~-
Please watch: "Dr. Rakesh Kumar : About India's VaccineScenario | pediatric Oncall "
https://www.youtube.com/watch?v=UVn6k5moI2s
-~-~~-~~~-~~-~-

26:29

MDR-TB in Children- Mercedes Becerra (Harvard Medical School)

Day 1, Part 12: HU CFAR Annual Symposium
The HU CFAR Annual Symposium was held at the Ra...

Second line medications for MDR-TB treatment; new ...

Managing injectable drugs in children treated for ...

Latest News for: Mdr tb

India aims to win its war on TB by 2025, but the goal seems too far-fetched ... A Call to ActionAgainstChildTB’, stated that less than 2% of the 3.6 lakh children with latent TB in India who are eligible for preventive therapy as per WHO guidelines actually got it ... Additionally, Dr Singhal said the absence of child-friendly formulations, mainly those to treat MDR-TB, add to the challenges to treat childhood TB....

The report, released by international voluntary scientific organisation The Union, shows that only 1.84 per cent of children, aged up to 14, in India receive preventive TB treatment ... The burden of multi drug-resistant TB (MDR-TB) in children is still largely unknown, but it is estimated that less than 10 per cent of all children with MDR-TB are detected and treated,” the report said....

Tuberculosis, a disease fueled by poverty, overcrowding and undernutrition, is a global barometer of deprivation. Of the more than 4,000 men, women and children TB kills every day, most are poor.TB's connection to poverty is explained, in large part, by the way Mycobacterium tuberculosis operates. It causes disease in only a fraction of the people it infects....

Tuberculosis, a disease fueled by poverty, overcrowding and undernutrition, is a global barometer of deprivation. Of the more than 4,000 men, women and children TB kills every day, most are poor.TB's connection to poverty is explained, in large part, by the way Mycobacterium tuberculosis operates. It causes disease in only a fraction of the people it infects ... ....

TB treatment. Data analysed across 20 countries showed that India recorded 1.2 lakh children, the maximum, who contracted TB in 2016, followed by China at 53,000 and Philippines at 37,000 children aged up to 14 ... ....